Coherent Biopharma is a biotechnology company that develops Bi-XDC technology to transform undruggable molecules and targets into druggable entities. The company focuses on addressing unmet medical needs in cancer and other areas.

Coherent Biopharma

Established in 2016, Coherent Biopharma’s proprietary bi-targeting XDC technology platform includes BESTTM Platform, C-PROTAC Platform and Chronic Diseases Platform. With the possibility to actively and cell/tissue specifically deliver any bioactive molecule, bi-targeting XDC technology of CBP has the potential to overcome the undruggability obstacle of a variety of molecules with high bioactivity, thus to Drug the Undruggable, and pioneer a new pathway of drug development.

COHE

COM:COHERENTBIO

Coherent Biopharma